Biological Skin Rejuvenation in the Regenerative Era: Clinical Applications of Exosomes and Polynucleotides in Modern Dermatology
DOI:
https://doi.org/10.64784/270Keywords:
Regenerative dermatology, Exosomes, Polynucleotides, Skin rejuvenation, Regenerative medicine, Aesthetic dermatology, Fibroblasts, Collagen synthesis, Extracellular matrix, Angiogenesis, Tissue repair, Photoaging.Abstract
Regenerative dermatology has emerged as a transformative field that integrates advances in regenerative medicine, molecular biology, and aesthetic dermatology to promote tissue repair through biological rather than purely corrective mechanisms. Among the most promising innovations, exosomes and polynucleotides have attracted considerable scientific attention because of their ability to stimulate fibroblast activity, enhance collagen synthesis, regulate inflammatory responses, promote angiogenesis, and improve extracellular matrix remodeling. The objective of this review was to analyze the current scientific evidence regarding the biological foundations, clinical applications, therapeutic effectiveness, safety profile, and future perspectives of these next-generation regenerative therapies. A narrative literature review was conducted following the scientific method using peer-reviewed publications from major biomedical databases. The available evidence demonstrates encouraging results in facial rejuvenation, photoaging, scar remodeling, chronic wound healing, periocular rejuvenation, and hair restoration, with improvements in skin quality and high patient satisfaction while maintaining a favorable short-term safety profile. Nevertheless, important methodological limitations remain, including heterogeneous treatment protocols, limited randomized clinical trials, and insufficient long-term follow-up. Continued international collaboration, standardized manufacturing processes, rigorous regulatory frameworks, and high-quality multicenter clinical studies will be essential to establish evidence-based therapeutic guidelines and consolidate regenerative dermatology as a mature clinical discipline.
References
[1] H. Shi, M. Wang, Y. Sun, D. Yang, W. Xu and H. Qian, “Exosomes: Emerging Cell-Free Based Therapeutics in Dermatologic Diseases,” Frontiers in Cell and Developmental Biology, vol. 9, Art. no. 736022, 2021, doi: 10.3389/fcell.2021.736022.
[2] G. H. Yang et al., “Overcome the Barriers of the Skin: Exosome Therapy,” Biomaterials Research, vol. 25, no. 22, 2021, doi: 10.1186/s40824-021-00224-8.
[3] S. R. Hussain and S. A. Jalian, “Update on Exosomes in Aesthetics,” Dermatologic Surgery, vol. 48, no. 7, pp. 824–830, 2022.
[4] A. Alzahrani et al., “Exosomes in Skin Rejuvenation: Systematic Review of Anti-Aging Effects and Clinical Applications,” Dermatology Practical & Conceptual, vol. 16, no. 1, 2026, doi: 10.5826/dpc.1601a6462.
[5] A. Abdelmaksoud, H. Goldust and M. Vestita, “Role of Exosomes in Skin Diseases,” International Journal of Dermatology, vol. 61, no. 10, pp. 1180–1192, 2022.
[6] M. Xiong et al., “The Novel Mechanisms and Applications of Exosomes in Dermatology and Cutaneous Medical Aesthetics,” Pharmacological Research, vol. 166, Art. no. 105490, 2021.
[7] R. Kalluri and V. S. LeBleu, “The Biology, Function, and Biomedical Applications of Exosomes,” Science, vol. 367, no. 6478, eaau6977, 2020.
[8] J. D. McBride, L. Rodriguez-Menocal and E. V. Badiavas, “Extracellular Vesicles as Biomarkers and Therapeutics in Dermatology: A Focus on Exosomes,” Journal of Investigative Dermatology, vol. 137, no. 8, pp. 1622–1629, 2017.
[9] S. B. Kim, H. J. Lee and Y. S. Park, “Polynucleotides for Skin Regeneration and Rejuvenation: Current Evidence and Future Perspectives,” Journal of Cosmetic Dermatology, vol. 22, no. 8, pp. 2135–2145, 2023.
[10] G. Cavallini and A. Sito, “Polynucleotides and Hyaluronic Acid in Skin Rejuvenation: Biological Rationale and Clinical Applications,” Aesthetic Medicine, vol. 8, no. 2, pp. 51–60, 2022.
[11] F. Guizzardi et al., “Polynucleotides Highly Purified Technology (PN-HPT®): Mechanisms of Action and Clinical Applications in Regenerative Medicine,” Drugs in Context, vol. 11, 2022.
[12] G. Sito, A. Manzoni and G. Sommariva, “Experimental Evidence Supporting the Regenerative Properties of Polynucleotides,” Clinical, Cosmetic and Investigational Dermatology, vol. 15, pp. 1763–1775, 2022.
[13] C. De Luca, M. Baldi and G. Cavallini, “Skin Quality Improvement with Polynucleotide-Based Treatments: Current Clinical Evidence,” Journal of Cosmetic Dermatology, vol. 23, no. 1, pp. 87–97, 2024.
[14] Y. S. Kim et al., “Clinical Applications of Polydeoxyribonucleotide (PDRN) in Tissue Repair and Regenerative Medicine,” International Journal of Molecular Sciences, vol. 24, no. 9, 2023.
[15] M. J. Alves, A. R. Ferreira and P. M. Costa, “Extracellular Vesicles for Skin Repair and Regeneration,” Cells, vol. 11, no. 12, 2022.
[16] M. Griffin, J. I. Almadori and D. Butler, “Use of Extracellular Vesicles in Wound Healing and Skin Regeneration,” International Wound Journal, vol. 19, no. 6, pp. 1410–1425, 2022.
[17] H. S. Park, J. H. Lee and K. S. Kim, “Stem Cell-Derived Exosomes for Cutaneous Regeneration,” Stem Cell Research & Therapy, vol. 13, no. 1, 2022.
[18] S. H. Lee, J. W. Kim and H. J. Kim, “Regenerative Dermatology: Current Perspectives in Cell-Free Therapy,” Journal of Clinical Medicine, vol. 12, no. 4, 2023.
[19] S. C. Wollina, “Regenerative Aesthetic Dermatology: New Concepts Beyond Conventional Skin Rejuvenation,” Journal of Cutaneous and Aesthetic Surgery, vol. 16, no. 2, pp. 75–84, 2023.
[20] M. S. B. Pagano, A. Cavallini and G. Sito, “Points to Ponder on the Role of Polynucleotides in Regenerative and Aesthetic Medicine: A Systematic Review,” Aesthetic Plastic Surgery, vol. 48, 2024.
